EpSSG News

04 December 2019



London December (4), 5-6, 2019

Location: Allen & Overy offices, London, United Kingdom

Official EpSSG Winter Meeting 2019 Our meeting will take place at the Allen & Overy Offices in…
Read more
24 October 2019

Board Meeting in Lyon

EpSSG Board meeting in Paris this October
The next Board meeting will be held in Lyon and is hosted from Dr. Christophe Bergeron. This meeting…
Read more
24 September 2019

Pediatric Soft Tissue Sarcoma Conference

Deadline: 6 January 2020

Texas Children’s Cancer Center is pleased to announce the 2020 Pediatric Soft Tissue Sarcoma Conference to be held on February 6-7, 2020 in Houston, TX. Please see attached agenda for a full line-up of speakers. In addition to oral presentations, we will accept abstract submissions for a poster session and top scoring abstracts will receive awards. This will be a great opportunity for trainees, so please feel free to forward to them in addition to your colleagues. We hope that you can join us in Houston!

Registration is required, but complimentary. Registration and lodging information can be found at texaschildrens.org/sarcomaconference

Read more
27 May 2019

Annual REPORT 2018

This report summarises the main EpSSG activities that have been developed in 2018. Importantly, we have had the opportunity to welcome parents of sarcoma patients to collaborate with us and support the development of our activities since 2016.
Further information is available on the EpSSG website: www.epssgassociation.it

Read more
23 May 2019

EpSSG Spring Prague MEETING 2019

EPSSG Spring Meeting Prague 2019

Prague May 23-24 2019

Location: Prague, Czech Republic

Official EpSSG Spring Meeting 2019 within SIOP Europe Annual MeetingOur meeting this year will take…
Read more
07 February 2019

NEW EpSSG PAPER first of 2019!!

Indeterminate pulmonary nodules at diagnosis in rhabdomyosarcoma; Are they clinically significant? A report from the European paediatric Soft tissue sarcoma Study Group

January 31, 2019 the EpSSG study entitled 'Indeterminate pulmonary nodules at diagnosis in rhabdomyosarcoma; Are they clinically significant? A report from the European paediatric Soft tissue sarcoma Study Group' was published online in Journal of Clinical Oncology. In this study we assessed the clinical value of small lung nodules, not fulfilling the criteria for pulmonary metastases. This was an EpSSG radiology study, conducted in 15 larger centers in the United Kingdom, France, Italy and the Netherlands. We showed that small lung nodules are a frequently encountered diagnostic problem, occurring in over 20% of the patients with otherwise localized rhabdomyosarcoma. More importantly, this study showed that the presence of small lung nodules did not impact survival in patients with otherwise localized rhabdomyosarcoma, treated according to the RMS2005 protocol for localized disease. This study proves that patients with small lung nodules do not require additional chest radiotherapy and/or intensified chemotherapy. These results will be used in the upcoming EpSSG Frontline and Relapsed-RMS study.

Read more